Detailed GuideMHRA
Clinical trials for medicines: ending a clinical trial
Guidance on the process for ending a clinical trial.
First published: Jun 24, 2025Last updated: Jul 6, 2026Changes: 6
Latest change: Clarified requirements and linked to additional guidance for submission of results where the trial is sponsored by the holder of a UK marketing authorisation and involves the use of that authorised medicinal product use in a paediatric population.
The full document, source attachments, and change history are available on KeyPedia. Sign in to view.